This post does not represent the views of my employer or any affiliated organization) #Diabetes #Type2Diabetes #InsulinIcodec #Awiqli #NovoNordisk #Endocrinology #Pharma #Innovation #Healthcare #ClinicalResearch Novo Nordisk Launches Awiqli Insulin Icodec in India Novo Nordisk launches Indias first once-weekly basal insulin Awiqli (insulin icodec) A significant milestone in diabetes care, Novo Nordisk has launched Awiqli (insulin icodec) in India, making once-weekly basal insulin therapy available to people living with type 2 diabetes
Management strategies include dietary adjustments, behavioral changes, and potentially adjusting medication with the guidance of a healthcare professional
Medication Interactions Certain medications used to treat lupus can interact with Ozempic, affecting its efficacy or safety
You can then make an informed decision for yourself
If weight increases during use, examine caloric intake, activity levels, and other variables
Neuroglia in psychiatric disorders